1. FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. (23rd January 2014) Authors: Genovese, M.; Sebba, A.; Rubbert-Roth, A.; Scali, J.; Alten, R.; Kremer, J.; Pitts, L.; Vernon, E.; van Vollenhoven, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗